METIS
Live / Registered — Registered (as of 28 Apr 2026)
What this means for you
Registered since 28 Apr 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Apr 2032: the §8 declaration of use).
Record
- Serial number
- 90795166
- Registration number
- 8232331
- Mark type
- Word mark
- Filed
- 25 Jun 2021
- Published for opposition
- 22 Nov 2022
- Registered
- 28 Apr 2026
- Next maintenance filing
- §8 declaration of use, due by 28 Apr 2032 (grace period to 28 Oct 2032)
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for target delivery of small molecules, RNA and gene therapies for central nervous system diseases, liver diseases, lung diseases, cancer, immune system diseases, rare diseases caused by genetic anomalies, kidney diseases, gastrointestinal diseases, and infectious diseases; drug delivery agents in the form of lipid nanoparticles, and sustained and controlled release formulations that facilitate the delivery of pharmaceutical preparations and improve the patients' medication experience
- Class 042 — Scientific and technological services: pharmaceutical research and development services
Owner
- METIS THERAPEUTICS INC., CAMBRIDGE, MA, US
- METIS THERAPEUTICS INC., CAMBRIDGE, MA, US
- METIS THERAPEUTICS INC., CAMBRIDGE, MA, US
- Metis Pharmaceuticals US Inc., Cambridge, MA, US
Prosecution history
- 28 Apr 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Apr 2026 — REGISTERED-PRINCIPAL REGISTER
- 03 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Dec 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Dec 2025 — USE AMENDMENT FILED
- 22 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 12 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Dec 2025 — SOU EXTENSION 5 GRANTED
- 06 Jul 2025 — SOU EXTENSION 5 FILED
- 12 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Nov 2024 — SOU EXTENSION 4 GRANTED
- 22 Nov 2024 — SOU EXTENSION 4 FILED